Denali Advisors LLC Trims Holdings in Cabot Corporation $CBT
Denali Advisors LLC has reduced its stake in Cabot Corporation (NYSE:CBT) by 18.9% in the second quarter, selling 20,212 shares but still retaining 86,707 shares valued at approximately $7.9 million. This adjustment comes as institutional investors collectively own 93.18% of Cabot's stock, and the company reported strong quarterly earnings of $1.67 EPS, beating analyst estimates, and a revenue increase of 6.4% year over year to $982 million. Despite a recent sale of shares by CEO Sean D. Keohane and mixed analyst ratings, Cabot declared a quarterly dividend of $0.4725 per share, maintaining a consensus "Hold" rating and an $89 price target.
Foster & Motley Inc. Invests $1.19 Million in Cabot Corporation $CBT
Foster & Motley Inc. has acquired a new stake of 13,152 shares in Cabot Corporation, valued at approximately $1.19 million during the second quarter. Other institutional investors like BlackRock Inc. and Deutsche Bank AG also increased their positions. This comes as CEO Sean D. Keohane sold over 91,000 shares, and analysts have issued mixed ratings for the specialty chemicals company.
CBT4847793 Bond Profile — Key Metrics
This article provides key metrics for the Cabot Corporation bond CBT4847793, which has a 4.0% coupon and matures on July 1, 2029. It details the bond's issue date, outstanding amount, face value, and minimum denomination. The article also includes a brief overview of Cabot Corp. as a global specialty chemicals and performance materials company.
CBT6483410 Bond Yield and Price — FINRA:CBT6483410
This article provides detailed information on the CBT6483410 bond issued by Cabot Corporation, including its yield, price, and key terms like coupon rate, maturity date, and face value. It also outlines bond information such as the issuer's sector, industry, and identifiers, along with a company profile of Cabot Corp. The page offers a glimpse into advanced bond data for registered users and lists various TradingView products and community features.
Oppenheimer Asset Management Inc. Makes New $4.53 Million Investment in Cabot Corporation $CBT
Oppenheimer Asset Management Inc. recently invested $4.53 million in Cabot Corporation, purchasing 49,852 shares. This new stake highlights institutional interest, as hedge funds and institutional investors collectively own 93.18% of the company. Cabot reported strong quarterly financials, beating analyst revenue and earnings estimates, and maintained its fiscal 2026 EPS guidance while also declaring a quarterly dividend.
Cabot Corporation Announces $350 Million 4.950% Notes Due 2029 Offering
Cabot Corporation has announced a $350 million offering of 4.950% notes due 2029, detailed in an 8-K filing with the SEC. The Underwriting Agreement was signed on August 12, 2026, with major financial institutions serving as lead underwriters. The offering is expected to close around August 21, 2026, subject to customary closing conditions.
American Century entities (CBT) disclose over 5% ownership in Cabot Corporation
American Century ETF Trust and its affiliated entities have disclosed beneficial ownership exceeding 5% in Cabot Corporation common stock. American Century ETF Trust holds 2,640,178 shares, representing 5.1% of the outstanding common stock, while American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research each report 2,768,176 shares, or 5.4%. These entities possess sole voting and dispositive power over their respective holdings, as detailed in a recent SCHEDULE 13G SEC filing.
CABOT CORP - NOTES SOLD AT 99.993% OF FACE AMOUNT
Cabot Corp. has sold notes at 99.993% of their face amount. The article is a brief news announcement from Reuters, indicating a financial transaction by the company. Further details require logging into the platform where the article is hosted.
Wellington group discloses 2.4M Cabot Corporation (CBT) shares under management
Wellington Management Group LLP and its related entities have updated their ownership report for Cabot Corporation (CBT), disclosing beneficial ownership of 2,416,471 shares, which represents 4.68% of the common stock. The filing indicates shared voting power over 1,870,169 shares and shared dispositive power over all 2,416,471 shares, with no single client holding more than five percent of the class. These shares are held on behalf of clients of Wellington-affiliated investment advisers.
Cabot Corporation Prices $350 Million 4.950% Senior Notes Due 2029
Cabot Corporation announced the pricing of a public offering of $350 million in 4.950% senior unsecured notes due 2029. The sale is expected to close on August 21, 2026, with proceeds intended to repay existing senior unsecured notes due September 2026, and for working capital and general corporate purposes. Citigroup Global Markets Inc., J.P. Morgan Securities LLC, PNC Capital Markets LLC, U.S. Bancorp Investments, Inc., BofA Securities, Inc., BBVA Securities Inc. and ING Financial Markets LLC are the joint book-running managers for the offering.
Cabot Sets 4.950% Interest on $350M Senior Notes Due 2029
Cabot Corporation has priced a public offering of $350 million in 4.950% senior unsecured notes due 2029, with interest to be paid semiannually. The offering is expected to close on August 21, 2026, and the net proceeds will primarily be used to repay existing senior unsecured notes due September 2026, with remaining funds allocated for working capital and general corporate purposes. Joint book-running managers include Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, among others.
Cabot CEO Sean Keohane sells $7.9m in stock
Cabot Corp CEO Sean D. Keohane sold approximately $7.9 million worth of common stock on August 7, 2026, after exercising employee stock options. The shares were sold at a weighted average price of $86.4053, following his acquisition of the shares at $62.24 each. After the transaction, Keohane directly holds 404,134 shares of Cabot common stock.
Cabot CEO Sean Keohane sells $7.9m in stock
Cabot Corp CEO Sean Keohane sold common stock worth approximately $7.9 million on August 7, 2026, after exercising employee stock options. He acquired 91,923 shares at $62.24 each and then sold them at a weighted average price of $86.4053. Following these transactions, Keohane directly holds 404,134 shares and indirectly owns an additional 14,263.7411 shares.
CBT Q3 Earnings Beat Estimates on Performance Chemicals Strength
Cabot Corporation (CBT) reported adjusted earnings of $1.67 per share for Q3 fiscal 2026, exceeding the Zacks Consensus Estimate, despite a 12.1% year-over-year decrease. Revenues also surpassed expectations, rising 6.4% to $982 million, driven by strong performance in its Performance Chemicals segment. The company tightened its fiscal 2026 adjusted earnings guidance and reaffirmed its EBITDA outlook for battery materials.
California State Teachers Retirement System Buys 12,850 Shares of Cabot Corporation $CBT
The California State Teachers Retirement System increased its stake in Cabot Corporation (NYSE:CBT) by 25.4% in the first quarter, purchasing 12,850 additional shares to bring its total holding to 63,369 shares valued at approximately $4.8 million. Other institutional investors also adjusted their positions in Cabot, which reported strong quarterly earnings with EPS of $1.67 and revenue up 6.4% year over year to $982 million. The company announced a quarterly dividend of $0.4725 per share, and analysts currently hold an average "Hold" rating with an $89 price target.
Bank of America Corp DE Has $114.18 Million Holdings in Cabot Corporation $CBT
Bank of America Corp DE has reported holdings of $114.18 million in Cabot Corporation (NYSE:CBT), despite trimming its position by 0.9% in the first quarter. Institutional investors collectively own 93.18% of Cabot, with several firms modifying their holdings. Analyst sentiment remains cautious, with a consensus "Hold" rating and an average price target of $89.00 for the specialty chemicals company.
CABOT CORP SEC Filing (Aug 7, 2026)
This article reports on a Form 144 SEC filing by Cabot Corp (CBT) on August 7, 2026. The filing indicates a proposed sale of 91,923 shares of common stock with an aggregate market value of $7,942,635.31 by an individual through Fidelity Brokerage Services LLC, acquired via stock option exercise on the same date. The document provides details on the filer, issuer, securities to be sold, and attestation regarding material adverse information.
Cabot Reinforcement Materials earnings fall despite higher volumes
Cabot Corp.'s Reinforcement Materials business reported a 24% year-on-year drop in third
Cabot Corp (CBT) Shares Surge 3.1% -- What GF Score of 79 Tells Investors
Cabot Corp (CBT) shares surged 3.1% to $84.54, but are considered 10.7% overvalued according to GuruFocus' GF Value™ estimate of $76.37. Despite a strong GF Score™ of 79/100, indicating above-average performance, the stock's P/E ratio is significantly higher than its historical median. The mixed activity among gurus and the absence of insider transactions suggest a cautious outlook for potential investors.
Cabot Corp (CBT) (Q3 2026) Earnings Call Highlights: Strong Performance Chemicals Growth and ...
Cabot Corp (CBT) reported adjusted EPS of $1.67 in Q3 fiscal 2026, a 4% sequential increase, driven by strong performance in its Performance Chemicals segment, which saw EBIT rise 19% year-over-year. The company reaffirmed its fiscal 2026 EBITDA expectation for battery materials at $40 million and is making strategic investments in capacity expansion.
CABOT CORP : UBS CUTS TARGET PRICE TO $92 FROM $97
UBS has cut its target price for Cabot Corp (CBT.N) shares to $92 from $97. This information was reported by Reuters on August 5, 2026. The article advises readers that the content reflects only the author's opinion and is not investment advice.
Cabot Corp. Down Over 9%, on Pace for Largest Percent Decrease Since June 2022 -- Data Talk
Cabot Corp. (CBT) experienced a significant drop of over 9% in its stock price, marking its largest percentage decrease since June 2022. This downturn places the stock on track for a notable daily decline.
Cabot Corp 3Q FY2026: Revenue $982M, EPS $0.12— 10-Q Summary
Cabot Corp (CBT) reported third-quarter fiscal 2026 results with revenue reaching $982 million, a 6.3% increase year-over-year. However, net income attributable to the company plummeted to $6 million from $101 million in the prior year, leading to a diluted EPS of $0.12, down from $1.86, primarily due to restructuring and a pension settlement charge. The company saw sequential sales growth driven by higher volumes in both segments, particularly in Asia Pacific and the Americas, though overall nine-month sales were impacted by weaker pricing.
Cabot Corp. Down Over 9%, on Pace for Largest Percent Decrease Since June 2022 -- Data Talk
Cabot Corporation (CBT) is experiencing a significant drop, down over 9% and trading at $81.06, which would be its lowest close since June 2026. This puts the company on track for its largest percentage decrease since June 2022. Despite this, CBT is still up 22.3% year-to-date and 1.2% from 52 weeks ago.
Cabot Corp. Down Over 9%, on Pace for Largest Percent Decrease Since June 2022 -- Data Talk
Cabot Corporation (CBT) experienced a significant drop of over 9%, trading at $81.06, and is on track for its largest percent decrease since June 2022. This decline places it near its lowest close since June 2026, despite being up 22.3% year-to-date. The stock has seen a 30.72% decrease from its all-time closing high in November 2024 and traded as low as $78.58 intraday.
Cabot Corporation $CBT Stock Holdings Lowered by Eastern Bank
Eastern Bank has reduced its stake in Cabot Corporation (NYSE:CBT) by 8.9% during the second quarter, selling 19,759 shares. Despite this, other institutional investors like Norges Bank and AQR Capital Management LLC increased their holdings. Analysts currently have a consensus "Hold" rating on Cabot with a target price of $85.80.
Cabot Corp earnings beat by $0.02, revenue topped estimates
Cabot Corp (NYSE: CBT) reported strong third-quarter results, beating analyst estimates for both EPS and revenue. The company posted an EPS of $1.67 against an estimated $1.65, and revenue of $982 million, surpassing the consensus of $927.44 million. Cabot Corp also provided guidance for FY 2026 EPS between $6.15 and $6.45, with its stock showing significant gains over the last 3 and 12 months.
Cabot Corporation Reports Third Quarter Fiscal Year 2026 Results
Cabot Corporation reported strong third-quarter fiscal year 2026 results with diluted EPS of $0.12 and Adjusted EPS of $1.67, driven by robust performance in its Performance Chemicals segment. The company is expanding its battery materials product line capacity, reaffirming its EBITDA expectations for fiscal 2026, and announced a planned leadership transition with Erica McLaughlin set to succeed Sean Keohane as President and CEO. Cabot also tightened its fiscal 2026 Adjusted EPS guidance range to $6.15 to $6.45 per share.
Cabot names new CEO as Keohane retires
Cabot Corp. has announced that chief financial officer Erica McLaughlin will take over as president and CEO on October 1, succeeding Sean Keohane, who is retiring. Keohane will stay on in an advisory role through the end of 2026 to ensure a smooth transition, while the company searches for a new CFO. Board chairman Michael Morrow highlighted McLaughlin's deep industry expertise and understanding of Cabot's operations as key reasons for her appointment.
Lazard Asset Management LLC Buys 21,194 Shares of Cabot Corporation $CBT
Lazard Asset Management LLC significantly increased its stake in Cabot Corporation (NYSE:CBT) by purchasing an additional 21,194 shares, nearly doubling its position to 43,219 shares valued at $3.26 million. Other institutional investors also adjusted their holdings in Cabot, which reported strong quarterly EPS of $1.61 against expectations of $1.47, though revenue declined slightly year-over-year. The company announced a quarterly dividend and analysts maintain a cautious "Hold" rating with a consensus price target of $85.80.
*Cabot Corp: McLaughlin to Serve on Bd as a Member of Class of Directors Whose Term Expires at 2029 Annual Meeting of Stockholders >CBT
Cabot Corporation announced that McLaughlin will serve on its Board of Directors. McLaughlin has been appointed as a member of the class of directors whose term is set to expire at the 2029 Annual Meeting of Stockholders. This information was reported by Dow Jones on July 30, with the stock symbol >CBT.
Cabot names new CEO as Sean Keohane prepares to retire
Sean Keohane is retiring as president and CEO of Cabot Corp. after a nearly 25-year career with the company. Erica McLaughlin, currently the executive vice president, chief financial officer, and head of corporate strategy, will succeed Keohane in leading Cabot Corp.
Cabot Corp: McLaughlin Joined Co in 2002, Has Held Broad Range of Senior Leadership Positions Within Finance, Strategy Organizations and Reinforcement Materials Business >CBT
This article announces that Mr. McLaughlin joined Cabot Corporation in 2002 and has since held various senior leadership roles. His experience spans finance, strategy, and the reinforcement materials business. This suggests a significant and diverse career path within the company.
Healthcare of Ontario Pension Plan Trust Fund Trims Holdings in Cabot Corporation $CBT
The Healthcare of Ontario Pension Plan Trust Fund significantly reduced its stake in Cabot Corporation (NYSE: CBT) by 67.5% in the first quarter, selling 89,414 shares and retaining 43,128 shares worth approximately $3.25 million. Despite this, other institutional investors increased their holdings, and institutions collectively own 93.18% of Cabot's stock. Cabot reported strong quarterly earnings, exceeding estimates, and has issued positive fiscal 2026 EPS guidance, while analysts maintain a "Hold" rating with an average price target below the current stock price.
Cabot Corp (CBT) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Cabot Corp (CBT), noting its current valuation score of 7.94 within the Chemicals industry. It highlights the company's P/E ratio of 16.54, which is below its recent high but above its recent low. The analysis indicates that relevant data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company.
Cabot Corp (CBT) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Cabot Corp (CBT), outlining its current price momentum, support and resistance levels, and various technical indicator readings. It notes that CBT's current stock price is trading between a resistance level of 93.47 and a support level of 82.08, making it suitable for range-bound swing trading. The analysis also includes detailed readings for indicators like MACD, RSI, KDJ, and moving averages, with a summary indicating a "Neutral" signal for the stock.
Cabot Corp (CBT) Institutional Confidence
Cabot Corp (CBT) has an institutional shareholding score of 10.00, placing it first in the Chemicals industry. The institutional shareholding proportion is 101.87%, a slight decrease of 0.89% quarter-over-quarter. ETHSX is the largest institutional shareholder, holding 1.22% of shares outstanding after a significant increase in its holdings.
Cabot Corporation Announces Planned Leadership Transition
Cabot Corporation announced that President and CEO Sean Keohane will retire on September 30, 2026. Erica McLaughlin, Executive Vice President, CFO, and Head of Corporate Strategy, will succeed him as President and CEO and join the Board of Directors, effective October 1, 2026. Keohane will remain in an advisory role for a smooth transition, and the company has begun a search for a new CFO.
Cabot Number of Employees 2026 | Employee Count & Headcount Data
Cabot Corp. (CBT) has approximately 4,068 employees worldwide as of March 2026, marking a 3.5% growth since 2023 but a 0.9% decline year-over-year in 2026. The company is actively hiring, with 276 job postings in 2026, a 23.5% increase from 2025. The workforce is concentrated in North America, and the average salary is $72,697, though employee sentiment is neutral and declining.
Dimensional Fund Advisors LP Increases Holdings in Cabot Corporation $CBT
Dimensional Fund Advisors LP significantly increased its stake in Cabot Corporation, boosting its holdings by 4.8% to 1.74 million shares valued at $131.3 million. Despite a cautious "Hold" consensus rating from analysts, Cabot exceeded quarterly earnings expectations with $1.61 EPS and $904 million in revenue, also declaring a quarterly dividend of $0.4725. Institutional investors collectively own a substantial 93.18% of the specialty chemicals company.
Cabot Corp (CBT) Financial Health: Profitability & Balance Sheet Analysis
This article analyzes the financial health of Cabot Corp (CBT), assigning it a financial score of 8.05, which ranks it 16th out of 65 in the Chemicals industry. The analysis indicates robust financial status and average operating efficiency, despite recent declines in quarterly revenue and net profit. The report also touches on various quality dimensions like earnings, operational efficiency, growth potential, and shareholder returns, noting that relevant data for these metrics have not yet been disclosed by the company.
Cabot Corp (CBT) Balance Sheet
This article presents the quarterly and annual balance sheets for Cabot Corp (CBT), offering detailed financial data to evaluate its financial health. It includes key metrics such as cash and short-term investments, total assets, various liability categories, and shareholders' equity, allowing users to analyze liquidity, leverage, and return on equity. The content also addresses frequently asked questions regarding specific balance sheet items for Cabot Corp.
CBT|Cabot Corp|Price:89.400|Chg%:-0.750
This article provides a detailed financial overview of Cabot Corp (CBT), including its stock price, market capitalization, and P/E ratio. It presents comprehensive financial data from income statements, balance sheets, and cash flow statements, covering both quarterly and annual periods. The report highlights key financial indicators like EPS, Revenue, Net Profit, and various margins, along with an analyst rating of "HOLD" as of July 27, 2026.
Cabot (CBT) to Release Quarterly Earnings on Monday
Cabot (CBT) is scheduled to release its Q3 fiscal 2026 earnings on Monday, August 3rd, with analysts projecting $1.66 EPS and $943.2 million in revenue. The company previously exceeded estimates in Q2 2026, reporting $1.61 EPS against expectations of $1.47. Cabot has also declared a quarterly dividend of $0.4725 per share, yielding 2.1%, and currently holds a consensus "Hold" rating from Wall Street with an average price target of $85.80.
CBT|Cabot Corp|Price:91.550|Chg%:+0.500
This article provides a detailed profile of Cabot Corporation (CBT), a global specialty chemicals and performance materials company. It outlines the company's business scope, including its Reinforcement Materials and Performance Chemicals segments, and lists key financial data such as market capitalization and P/E ratio. The piece also details company information, executive leadership, and institutional shareholding data for Cabot Corp.
Cabot Corp (CBT) Cash Flow
This article provides a detailed cash flow statement for Cabot Corp (CBT), presenting quarterly and annual data for operating, investing, and financing cash flows, along with free cash flow. It includes definitions and explanations for each cash flow type and answers frequently asked questions regarding Cabot Corp's cash flow performance and capital expenditures.
Cabot Corp (CBT) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Cabot Corp (CBT), outlining its major institutional holders, types of shareholders, and changes in institutional holdings over time. Key shareholders include BlackRock, Wellington Management, and Vanguard, with investment advisors making up the largest share of shareholder types. The data provides insights into the concentration and evolution of institutional ownership in CBT.
Cabot Corp (CBT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for Cabot Corp (CBT), detailing its regional revenue contributions. The data shows that Asia Pacific is the largest revenue contributor, followed by the Americas, and then Europe, Middle East & Africa. Information regarding specific business segment contributions and profit by region is noted as not yet disclosed by the company.
Cabot Corp (CBT) Risk Assessment: Volatility, Financial Risk & Investment Risk
Cabot Corp (CBT) has a current risk assessment score of 7.53, placing it 21st out of 65 in the Chemicals industry. The company's beta is 0.81, indicating it tends to underperform in bull markets but offers more resilience in bear markets. The assessment includes detailed metrics on volatility, maximum drawdown, Sharpe ratio, and liquidity, highlighting various risk and return characteristics of the stock over different periods.
Cabot stock trades steadily as specialty chemicals margins support valuation
Cabot Corporation's stock maintains a steady valuation supported by strong performance in its specialty chemicals and performance materials business. The company reported healthy revenue and profit growth in fiscal 2024, with improved operating margins and disciplined capital allocation. Its financial stability, moderate leverage, and balanced shareholder returns contribute to a favorable market perception despite exposure to cyclical markets.
